LEXICON PHARMACEUTICALS, INC. Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of -$23.12 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Notes › Earnings Per Share › Undistributed Earnings (Loss) Available to Common Shareholders, Diluted
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2021-11-09
- LEXICON PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2021-09-30 was -$23.12M, a 127.57% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2020-09-30 was $83.86M, a 63.12% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2019-09-30 was $227.36M.
- LEXICON PHARMACEUTICALS, INC. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2018-09-30 was -$27.40M.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 9 month |
|---|---|---|
| 2021-09-30 | -$23.12M 10-Q · filed 2021-11-09 | -$62.15M 10-Q · filed 2021-11-09 |
| 2020-09-30 | $83.86M 10-Q · filed 2021-11-09 | -$53.08M 10-Q · filed 2021-11-09 |
| 2019-09-30 | $227.36M 10-Q · filed 2020-10-30 | $185.06M 10-Q · filed 2020-10-30 |
| 2018-09-30 | -$27.40M 10-Q · filed 2019-11-07 | -$103.77M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |